Moderna, Inc.
MRNA
$53.57
$1.863.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.82B | -3.12B | -2.90B | -3.36B | -3.56B |
| Total Depreciation and Amortization | 215.00M | 208.00M | 208.00M | 192.00M | 189.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 501.00M | 519.00M | 498.00M | 462.00M | 446.00M |
| Change in Net Operating Assets | 233.00M | 411.00M | -500.00M | -349.00M | -78.00M |
| Cash from Operations | -1.87B | -1.98B | -2.70B | -3.05B | -3.00B |
| Capital Expenditure | -192.00M | -675.00M | -793.00M | -972.00M | -1.05B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.14B | 2.13B | 2.27B | 3.53B | 3.00B |
| Cash from Investing | 1.95B | 1.46B | 1.48B | 2.56B | 1.95B |
| Total Debt Issued | 600.00M | -4.00M | -1.00M | 2.00M | 0.00 |
| Total Debt Repaid | -18.00M | -16.00M | -13.00M | -9.00M | -10.00M |
| Issuance of Common Stock | 35.00M | 30.00M | 36.00M | 54.00M | 66.00M |
| Repurchase of Common Stock | -2.00M | -1.00M | -1.00M | -1.00M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.00M | -- | -- | -- | -- |
| Cash from Financing | 593.00M | 9.00M | 21.00M | 46.00M | 56.00M |
| Foreign Exchange rate Adjustments | 2.00M | 1.00M | 1.00M | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 668.00M | -513.00M | -1.20B | -445.00M | -999.00M |